Cargando…

Serum Bile Acids Profiling in Inflammatory Bowel Disease Patients Treated with Anti-TNFs

Background: Inflammatory bowel diseases (IBD), ulcerative colitis (UC), and Crohn’s disease (CD), represent systematic chronic conditions with a deficient intestinal absorption. We first attempt to investigate the serum bile acids (sBAs) profile in a large cohort of IBD patients to evaluate changes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roda, Giulia, Porru, Emanuele, Katsanos, Konstantinos, Skamnelos, Alexandros, Kyriakidi, Kallirroi, Fiorino, Gionata, Christodoulou, Dimitrios, Danese, Silvio, Roda, Aldo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721523/ https://www.ncbi.nlm.nih.gov/pubmed/31382518 http://dx.doi.org/10.3390/cells8080817

Ejemplares similares

Role of bile acids in inflammatory bowel disease
por: Tiratterra, Elisa, et al.
Publicado: (2018)

Biomarker Development in Chronic Inflammatory Diseases
por: Katsanos, Aristeidis H., et al.
Publicado: (2017)

Neutrophil anti-neutrophil cytoplasmic autoantibody proteins: bactericidal increasing protein, lactoferrin, cathepsin, and elastase as serological markers of inflammatory bowel and other diseases
por: Kyriakidi, Kallirroi S., et al.
Publicado: (2016)

Loss of Response to Anti-TNFs: Definition, Epidemiology, and Management
por: Roda, Giulia, et al.
Publicado: (2016)

Fast-track drug approval in inflammatory bowel diseases
por: Katsanos, Konstantinos H., et al.
Publicado: (2016)

CD4 count remission hypothesis in patients with inflammatory bowel disease and human immunodeficiency virus infection: a systematic review of the literature
por: Skamnelos, Alexandros, et al.
Publicado: (2015)

Specific Features of Patients With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis
por: Fousekis, Fotios S., et al.
Publicado: (2019)

Biomarkers for Optimization and Personalization of Anti-TNFs in Pediatric Inflammatory Bowel Disease
por: Salvador-Martín, Sara, et al.
Publicado: (2021)

Clostridium Difficile Infection in Patients Impact Suspected Cytomegalovirus Infection in Patients with Inflammatory Bowel Disease
por: Kosmidou, Maria, et al.
Publicado: (2020)

Association between Genetic Polymorphisms and Response to Anti-TNFs in Patients with Inflammatory Bowel Disease
por: Prieto-Pérez, Rocío, et al.
Publicado: (2016)

Analysis of fecal bile acids and metabolites by high resolution mass spectrometry in farm animals and correlation with microbiota
por: Porru, Emanuele, et al.
Publicado: (2022)

Protecting patients with IBD during the COVID-19 pandemic
por: Fiorino, Gionata, et al.
Publicado: (2020)

Long-term Administration of Nuclear Bile Acid Receptor FXR Agonist Prevents Spontaneous Hepatocarcinogenesis in Abcb4(−/−) Mice
por: Cariello, Marica, et al.
Publicado: (2017)

Bile acids and oxo-metabolites as markers of human faecal input in the ancient Pompeii ruins
por: Porru, Emanuele, et al.
Publicado: (2021)

Viral infections in inflammatory bowel disease: Tips and tricks for correct management
por: Craviotto, Vincenzo, et al.
Publicado: (2021)

The role of small-bowel endoscopy in inflammatory bowel disease: an updated review on the state-of-the-art in 2021
por: Skamnelos, Alexandros, et al.
Publicado: (2021)

Impact of simple, specific, verbal instructions on the quality of bowel preparation in hospitalized patients undergoing colonoscopy: a multicenter randomized controlled trial
por: Triantafyllou, Konstantinos, et al.
Publicado: (2021)

Intravenous Versus Oral Iron for the Treatment of Anemia in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Bonovas, Stefanos, et al.
Publicado: (2016)

Maintaining the Quality Standards of Care for Inflammatory Bowel Disease Patients During the COVID-19 Pandemic
por: Allocca, Mariangela, et al.
Publicado: (2020)

Incidence and Patterns of COVID-19 Among Inflammatory Bowel Disease Patients From the Nancy and Milan Cohorts
por: Allocca, Mariangela, et al.
Publicado: (2020)

Artificial Endoscopy and Inflammatory Bowel Disease: Welcome to the Future
por: Solitano, Virginia, et al.
Publicado: (2022)

Metabolic Bile Acid Profile Impairments in Dogs Affected by Chronic Inflammatory Enteropathy
por: Comito, Rossana, et al.
Publicado: (2023)

Corrigendum to ‘Fibroblast growth factor 19 modulates intestinal microbiota and inflammation in presence of farnesoid x receptor’: [EBioMedicine 54 (2020) 102719]
por: Gadaleta, Raffaella Maria, et al.
Publicado: (2020)

Fibroblast Growth Factor 19 modulates intestinal microbiota and inflammation in presence of Farnesoid X Receptor
por: Gadaleta, Raffaella Maria, et al.
Publicado: (2020)

Evolution and New Horizons of Endoscopy in Inflammatory Bowel Diseases
por: Parigi, Tommaso Lorenzo, et al.
Publicado: (2022)

Cross-Sectional Imaging Instead of Colonoscopy in Inflammatory Bowel Diseases: Lights and Shadows
por: Alfarone, Ludovico, et al.
Publicado: (2022)

Colorectal Cancer Surveillance in Patients with Inflammatory Bowel Diseases: Chromoendoscopy or Non-Chromoendoscopy, That Is the Question
por: Gabbiadini, Roberto, et al.
Publicado: (2022)

Histological Scores in Patients with Inflammatory Bowel Diseases: The State of the Art
por: Vespa, Edoardo, et al.
Publicado: (2022)

The Earlier You Find, the Better You Treat: Red Flags for Early Diagnosis of Inflammatory Bowel Disease
por: Cantoro, Laura, et al.
Publicado: (2023)

The IL23-IL17 Immune Axis in the Treatment of Ulcerative Colitis: Successes, Defeats, and Ongoing Challenges
por: Noviello, Daniele, et al.
Publicado: (2021)

Diversion proctocolitis and the problem of the forgotten rectum in inflammatory bowel diseases: A systematic review
por: Dal Buono, Arianna, et al.
Publicado: (2021)

A Surface Plasmon Resonance-based assay to measure serum concentrations of therapeutic antibodies and anti-drug antibodies
por: Beeg, Marten, et al.
Publicado: (2019)

Pseudopolyps in inflammatory bowel diseases: Have we learned enough?
por: Politis, Dimitrios S, et al.
Publicado: (2017)

Suppression of Hepatic Bile Acid Synthesis by a non-tumorigenic FGF19 analogue Protects Mice from Fibrosis and Hepatocarcinogenesis
por: Gadaleta, Raffaella Maria, et al.
Publicado: (2018)

Grading acute radiation bowel injury an unaddressed issue
por: Katsanos, Konstantinos H., et al.
Publicado: (2012)

Familial inflammatory bowel diseases in Northwest Greece
por: Katsanos, Konstantinos H., et al.
Publicado: (2015)

Use of anti-TNFs for difficult-to-treat urticaria: response to Cooke et al
por: Thomsen, Simon Francis, et al.
Publicado: (2015)

Patients with Inflammatory Bowel Disease Are Not at Increased Risk of COVID-19: A Large Multinational Cohort Study
por: Allocca, Mariangela, et al.
Publicado: (2020)

Pancreatic Involvement in Inflammatory Bowel Disease: A Review
por: Fousekis, Fotios S., et al.
Publicado: (2018)

Rediscovering histology: what is new in endoscopy for inflammatory bowel disease?
por: Solitano, Virginia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_oq0r9kn5rvsd8n1ll41drvvfho